Pyloric stenosis

From WikiMD's Food, Medicine & Wellness Encyclopedia

Pyloric stenosis is a condition that affects the gastrointestinal tract in infants. It is characterized by the narrowing of the pylorus, the lower part of the stomach that connects to the small intestine. This condition can cause severe vomiting, weight loss, and dehydration.

Symptoms and signs[edit | edit source]

The most common symptom of pyloric stenosis is projectile vomiting, which typically starts around three weeks of age. Other symptoms can include weight loss, dehydration, and changes in bowel movements. Infants with this condition may also appear to be constantly hungry.

Causes[edit | edit source]

The exact cause of pyloric stenosis is unknown, but it is believed to be a combination of genetic and environmental factors. Some studies suggest that certain antibiotics taken during pregnancy or in the first weeks of a baby's life can increase the risk of developing this condition.

Diagnosis[edit | edit source]

Diagnosis of pyloric stenosis involves a physical examination and medical history. The doctor may also order tests such as an ultrasound or a barium swallow to confirm the diagnosis.

Treatment[edit | edit source]

The primary treatment for pyloric stenosis is surgery, known as a pyloromyotomy. This procedure involves cutting the muscle of the pylorus to allow food to pass through more easily. Most infants recover quickly after surgery and have no long-term health effects.

Epidemiology[edit | edit source]

Pyloric stenosis is more common in males than in females, and it often runs in families. It is also more common in first-born children. The condition affects approximately 2 to 4 out of every 1,000 babies in the United States.

See also[edit | edit source]

Pyloric stenosis Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD